The Centers for Disease Control and Prevention (CDC) yesterday said it and health officials in multiple state are investigating Salmonella outbreaks tied to backyard poultry that have sickened 219 people, 1 fatally, in 38 states.
A study of 4,737 COVID-19 patients in Israel conducted during the Omicron surge concludes that Pfizer's antiviral drug Paxlovid roughly halves the risk of severe COVID-19 or death, according to findings published yesterday in Clinical Infectious Diseases.
Symptomatic COVID-19 cases are responsible for more viral transmission than asymptomatic infections, suggests an updated systematic review and meta-analysis of 130 studies published yesterday in PLOS Medicine.
While COVID-19–related thyroid inflammation usually resolves shortly after the acute illness, about half of participants in a study presented today at the 24th European Congress of Endocrinology still had thyroid abnormalities a year later. The congress is being held May 21 to 24 in Milan, Italy.
A systematic review and meta-analysis of clinical trials of antibiotic treatment for children with community-acquired pneumonia provides further support for shorter treatment duration, Finnish researchers reported yesterday in Clinical Infectious Diseases.
A related study shows how responding quickly to food illness outbreaks saves lives and significant money.
An increase in resistance to ciprofloxacin among poultry isolates was primarily due to Salmonella Infantis.
Venatorx Pharmaceuticals of Malvern, Pennsylvania, yesterday released promising data from a phase 3 trial of its investigational new drug for patients with complicated urinary tract infections (cUTIs).
Fewer than half of US states requiring COVID-19 vaccination or routine testing of schoolteachers included childcare professionals in their mandates, leaving some young children vulnerable to infection by unvaccinated caregivers, according to a study yesterday in JAMA Pediatrics.
The risk of hospitalization, intensive care unit (ICU) admission, and death was much lower among more than 9,000 Canadian COVID-19 patients infected with the Omicron variant than among matched Delta patients, according to a study published yesterday in JAMA.
The risk of hospitalization or death with Omicron was 41% of—and the risk of death was one-tenth of—that of Delta.
